MapLight Therapeutics defies government shutdown with IPO that raises more than $250 million

The government shutdown has left the SEC quiet, but a Peninsula biotech managed to go public anyway, lighting a path to Wall ...

Biotech MapLight Jumps 23% in First US IPO Using Shutdown Fix

MapLight Therapeutics Inc. shares jumped as much as 23% after the biotechnology firm raised $258.9 million in an initial ...

Novo-Backed MapLight Raises $258.9 Million in US IPO, Placement

MapLight Therapeutics Inc. will raise $258.9 million in an initial public offering and private placement, becoming the first ...
FierceBiotech

Fierce Biotech Fundraising Tracker '25: Hemab closes $157M series C; Electra shines with $183M

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last year's ...